Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sala, A
Right arrow Articles by Maclouf, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sala, A
Right arrow Articles by Maclouf, J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit

A Sala, GM Aliev, G Rossoni, F Berti, C Buccellati, G Burnstock, G Folco and J Maclouf

Center for Cardiopulmonary Pharmacology, University of Milan, Italy.

Morphological and functional modifications occurring in Langendorff rabbit heart preparations perfused with purified human leukocytes (PMNL), as an organ model of sulfidopeptide-leukotrienes (sLT) transcellular biosynthesis, were studied. Coronary perfusion pressure (CPP), monitored as an index of coronary vasospasm, increased by 295% after challenge with the Ca(2+)-ionophore A-23187 (0.5 micromol/L) for 30', accompanied by a significant formation of sLT. Increase in CPP was prevented by PMNL pretreatment with the 5-lipoxygenase inhibitor MK-886 (1 micromol/L) or by heart pretreatment with LTD4-receptor antagonist SKF 104353, indicating a pivotal role of PMNL-derived 5-lipoxygenase (5- LO) products in the observed functional modifications. Similar effects were obtained using granulocyte macrophage-colony stimulating factor- primed PMNL challenged with the tripeptide n-formyl-methionyl-leucyl- phenylalanine. Scanning electron microscopy (SEM) of coronary arteries showed craters on the vessel luminal surface, PMNL adhering to endothelial cells (EC), increased number of microvilli on EC, presence of nonviable, desquamating, fusiform EC. SEM and transmission electron microscopy of myocardial microvessels, showed presence of perivascular and intermuscle edema, presence of activated PMNL and decreased number of patent microvessels. These morphological alterations were significantly blunted by MK-886 or SKF 104353. These data provide evidence of close interaction between PMNL and myocardial EC, resulting in enhanced sLT formation via transcellular biosynthesis, originating from transfer of PMNL-derived LTA4 to EC. These potent proinflammatory autacoids are responsible for coronary vasospasm and the morphological alternations observed.

Volume 87, Issue 5, pp. 1824-1832, 03/01/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
G. Folco and R. C. Murphy
Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses
Pharmacol. Rev., September 1, 2006; 58(3): 375 - 388.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sjostrom, A.-S. Johansson, O. Schroder, H. Qiu, J. Palmblad, and J. Z. Haeggstrom
Dominant Expression of the CysLT2 Receptor Accounts for Calcium Signaling by Cysteinyl Leukotrienes in Human Umbilical Vein Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): e37 - 41.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Martel-Pelletier, D Lajeunesse, P Reboul, and J-P Pelletier
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
Ann Rheum Dis, June 1, 2003; 62(6): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Sala, G. Rossoni, F. Berti, C. Buccellati, A. Bonazzi, J. Maclouf, and G. Folco
Monoclonal Anti-CD18 Antibody Prevents Transcellular Biosynthesis of Cysteinyl Leukotrienes In Vitro and In Vivo and Protects Against Leukotriene-Dependent Increase in Coronary Vascular Resistance and Myocardial Stiffness
Circulation, March 28, 2000; 101(12): 1436 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sala, S. Zarini, G. Folco, R. C. Murphy, and P. M. Henson
Differential Metabolism of Exogenous and Endogenous Arachidonic Acid in Human Neutrophils
J. Biol. Chem., October 1, 1999; 274(40): 28264 - 28269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. V. Rybina, H. Liu, Y. Gor, and S. J. Feinmark
Regulation of Leukotriene A4 Hydrolase Activity in Endothelial Cells by Phosphorylation
J. Biol. Chem., December 12, 1997; 272(50): 31865 - 31871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sala, M. Bolla, S. Zarini, R. Muller-Peddinghaus, and G. Folco
Release of Leukotriene A4 Versus Leukotriene B4 from Human Polymorphonuclear Leukocytes
J. Biol. Chem., July 26, 1996; 271(30): 17944 - 17948.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020